Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 491

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Hereditary diffuse gastric cancer: updated clinical practice guidelines

Open access
Blair, Vanessa R, McLeod, Maybelle, Carneiro, Fátima, Coit, Daniel G, D'Addario, Johanna L, van Dieren, Jolanda M, Harris, Kirsty L, Hoogerbrugge, Nicoline, Oliveira, Carla, van der Post, Rachel S, Arnold, Julie, Benusiglio, Patrick R, Bisseling, Tanya M, Boussioutas, Alex, Cats, Annemieke, Charlton, Amanda, Schreiber, Karen E Chelcun, Davis, Jeremy L, Pietro, Massimiliano di, Fitzgerald, Rebecca C, Ford, James M, Gamet, Kimberley, Gullo, Irene, Hardwick, Richard H, Huntsman, David G, Kaurah, Pardeep, Kupfer, Sonia S, Latchford, Andrew, Mansfield, Paul F, Nakajima, Takeshi, Parry, Susan, Rossaak, Jeremy, Sugimura, Haruhiko, Svrcek, Magali, Tischkowitz, Marc, Ushijima, Toshikazu, Yamada, Hidetaka, Yang, Han-Kwang, Claydon, Adrian, Figueiredo, Joana, Paringatai, Karyn, Seruca, Raquel, Bougen-Zhukov, Nicola, Brew, Tom, Busija, Simone, Carneiro, Patricia, DeGregorio, Lynn, Fisher, Helen, Gardner, Erin, Godwin, Tanis D, Holm, Katharine N, Humar, Bostjan, Lintott, Caroline J, Monroe, Elizabeth C, Muller, Mark D, Norero, Enrique, Nouri, Yasmin, Paredes, Joana, Sanches, João M, Schulpen, Emily, Ribeiro, Ana S, Sporle, Andrew, Whitworth, James, Zhang, Liying, Reeve, Anthony E, Guilford, Parry·2020·The Lancet Oncology

Abstract

Hereditary Diffuse Gastric Cancer (HDGC) is an autosomal dominant cancer syndrome that is characterised by a high prevalence of diffuse gastric cancer and lobular breast cancer. It is largely caused by inactivating germline mutations in the tumour suppressor gene CDH1, although pathogenic variants in CTNNA1 occur in a minority of HDGC families. Here, the International Gastric Cancer Linkage Consortium (IGCLC) has updated practice guidelines for HDGC, recognising the emerging evidence of variability in gastric cancer risk between HDGC families, the growing capability of endoscopic and histological surveillance in HDGC and greater experience managing long-term sequelae post total gastrectomy in young patients. To redress the balance between the accessibility, cost and acceptance of genetic testing and greater identification of pathogenic variant carriers, the HDGC genetic testing criteria have been relaxed, mainly through less restrictive age limits. Prophylactic total gastrectomy remains the recommended option for gastric cancer risk management in pathogenic CDH1 variant carriers. However, there is increasing confidence from the IGCLC that endoscopic surveillance in expert centres can be safely offered to patients who wish to postpone surgery or to those whose risk is not well defined.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1470-2045(20)30219-9

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 491

Metadata

Authors
Blair, V. R., McLeod, M., Carneiro, F., Coit, D. G., D'Addario, J. L., van Dieren, J. M., Harris, K. L., Hoogerbrugge, N., Oliveira, C., van der Post, R. S., Arnold, J., Benusiglio, P. R., Bisseling, T. M., Boussioutas, A., Cats, A., Charlton, A., Schreiber, K. E. C., Davis, J. L., Pietro, M. D., Fitzgerald, R. C., Ford, J. M., Gamet, K., Gullo, I., Hardwick, R. H., Huntsman, D. G., Kaurah, P., Kupfer, S. S., Latchford, A., Mansfield, P. F., Nakajima, T., Parry, S., Rossaak, J., Sugimura, H., Svrcek, M., Tischkowitz, M., Ushijima, T., Yamada, H., Yang, H.-K., Claydon, A., Figueiredo, J., Paringatai, K., Seruca, R., Bougen-Zhukov, N., Brew, T., Busija, S., Carneiro, P., DeGregorio, L., Fisher, H., Gardner, E., Godwin, T. D., Holm, K. N., Humar, B., Lintott, C. J., Monroe, E. C., Muller, M. D., Norero, E., Nouri, Y., Paredes, J., Sanches, J. M., Schulpen, E., Ribeiro, A. S., Sporle, A., Whitworth, J., Zhang, L., Reeve, A. E., & Guilford, P.
Venue
The Lancet Oncology
Publisher
Elsevier BV
Published
2020-08
Volume
21
Issue
8
Pages
e386-e397
ISSN
1470-2045 (ISSN-L)
OpenAlex
W3047025380
Cited by
491
References
2
FWCI
33.62
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hereditary diffuse gastric cancer: updated clinical practice guidelines. https://app.cochat.ai/papers/10.1016/s1470-2045(20)30219-9
The paper
Blair, V. R., McLeod, M., Carneiro, F., Coit, D. G., D'Addario, J. L., van Dieren, J. M., Harris, K. L., Hoogerbrugge, N., Oliveira, C., van der Post, R. S., Arnold, J., Benusiglio, P. R., Bisseling, T. M., Boussioutas, A., Cats, A., Charlton, A., Schreiber, K. E. C., Davis, J. L., Pietro, M. D., . . . Guilford, P. (2020). Hereditary diffuse gastric cancer: updated clinical practice guidelines. The Lancet Oncology. https://doi.org/10.1016/s1470-2045(20)30219-9

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.